Oramed Pharmaceuticals (ORMP) EPS (Basic) (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted EPS (Basic) of $0.94 for Q1 2026, up 83.54% on a QoQ basis from $0.51 in Q4 2025, and up 606.9% year-over-year from $0.13 in Q1 2025.
Oramed Pharmaceuticals (ORMP) EPS (Basic) (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' EPS (Basic) history runs 15 years deep, the most recent figure standing at $0.94 for Q1 2026.
- Quarterly EPS (Basic) rose 606.9% year-over-year to $0.94 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.97 (up 533.2% YoY) and the FY2025 annual result came in at $1.82, up 488.2% from the prior year.
- EPS (Basic) was $0.94 for Q1 2026 at Oramed Pharmaceuticals, up from $0.51 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.16 in Q3 2025 and bottomed at -$0.48 in Q3 2024.
- A 5-year average of $0.08 and a median of -$0.08 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 788.43% — and 2025, when it plunged 593.43%.
- Oramed Pharmaceuticals' EPS (Basic) stood at -$0.3 in 2022, then soared by 210.23% to $0.33 in 2023, then plunged by 175.74% to -$0.25 in 2024, then surged by 304.93% to $0.51 in 2025, then jumped by 83.54% to $0.94 in 2026.
- Business Quant data shows ORMP's EPS (Basic) at $0.94 in Q1 2026, $0.51 in Q4 2025, and $1.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.51 |
| Sep 30, 2025 | 1.16 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.48 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | -0.27 |
| Mar 31, 2022 | -0.27 |
| Aug 31, 2021 | -0.78 |
| Nov 30, 2019 | -0.14 |
| Aug 31, 2019 | 1.51 |